Clinical Trial

Neurofeedback to Treat Depression - 2

Recruiting
View on ClinicalTrials.gov →
Summary
This study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD. This real-time fMRI neurofeedback therapy uses cloud-based pattern classification to decode a patient's attentional state and dynamically modulate task stimuli (in a closed loop) based on this state.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-09-03; most recent amendment 2025-12-02.
Status change: Not Yet Recruiting → Recruiting 2025-12-02
Trial Details
NCT Number NCT07159061
Lead Sponsor University of Pennsylvania
Conditions Major Depressive Disorder (MDD)
Enrollment 80 participants
Start Date 2025-11-21
Primary Completion 2028-11-21 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-04